应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00690 联康生物科技集团
交易中 05-19 11:58:10
0.091
+0.002
+2.25%
最高
0.091
最低
0.089
成交量
64.00万
今开
0.089
昨收
0.089
日振幅
2.25%
总市值
5.43亿
流通市值
5.43亿
总股本
59.71亿
成交额
5.75万
换手率
0.01%
流通股本
59.71亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
联康生物科技集团2026年4月股份变动月报:股本保持稳定
公告速递 · 05-04
联康生物科技集团2026年4月股份变动月报:股本保持稳定
联康生物科技集团(00690)建议终止现有购股权计划及采纳新购股权计划
智通财经 · 04-23
联康生物科技集团(00690)建议终止现有购股权计划及采纳新购股权计划
联康生物科技集团拟回购最多10%股份
公告速递 · 04-22
联康生物科技集团拟回购最多10%股份
联康生物科技集团2025年收入5.86亿元 净利同比增长12.7% 聚焦创新研发与国际化布局
公告速递 · 04-22
联康生物科技集团2025年收入5.86亿元 净利同比增长12.7% 聚焦创新研发与国际化布局
联康生物科技集团3月无新增发行或股份变动
公告速递 · 04-08
联康生物科技集团3月无新增发行或股份变动
联康生物科技集团(00690):股东股权框架变动
智通财经网 · 04-02
联康生物科技集团(00690):股东股权框架变动
联康生物科技集团(00690)发布年度业绩 年内溢利9332.7万港元 同比增加12.7%
智通财经网 · 03-28
联康生物科技集团(00690)发布年度业绩 年内溢利9332.7万港元 同比增加12.7%
联康生物科技集团将于2026年6月12日派发末期股息每股0.00313元
公告速递 · 03-27
联康生物科技集团将于2026年6月12日派发末期股息每股0.00313元
联康生物科技集团(00690)股东将股票存入香港上海汇丰银行 存仓市值8715.96万港元
智通财经 · 03-17
联康生物科技集团(00690)股东将股票存入香港上海汇丰银行 存仓市值8715.96万港元
联康生物科技集团盘中异动 早盘股价大跌7.27%报0.102港元
市场透视 · 03-09
联康生物科技集团盘中异动 早盘股价大跌7.27%报0.102港元
联康生物科技集团(00690)2026年2月股份维持不变
公告速递 · 03-03
联康生物科技集团(00690)2026年2月股份维持不变
联康生物科技集团盘中异动 大幅拉升5.56%
市场透视 · 02-27
联康生物科技集团盘中异动 大幅拉升5.56%
联康生物科技集团02月23日主力净流出59.6万元 散户资金买入
市场透视 · 02-23
联康生物科技集团02月23日主力净流出59.6万元 散户资金买入
联康生物科技集团02月09日主力净流入16.9万元 散户资金抛售
市场透视 · 02-09
联康生物科技集团02月09日主力净流入16.9万元 散户资金抛售
联康生物科技集团02月03日主力净流出23.1万元 散户资金买入
市场透视 · 02-03
联康生物科技集团02月03日主力净流出23.1万元 散户资金买入
联康生物科技集团盘中异动 快速拉升5.61%
市场透视 · 01-29
联康生物科技集团盘中异动 快速拉升5.61%
联康生物科技集团盘中异动 股价大跌5.31%报0.107港元
市场透视 · 01-27
联康生物科技集团盘中异动 股价大跌5.31%报0.107港元
智通港股股东权益披露|1月27日
智通财经 · 01-27
智通港股股东权益披露|1月27日
联康生物科技集团盘中异动 临近午盘股价大跌5.83%
市场透视 · 01-22
联康生物科技集团盘中异动 临近午盘股价大跌5.83%
联康生物科技集团盘中异动 早盘快速拉升5.36%
市场透视 · 01-07
联康生物科技集团盘中异动 早盘快速拉升5.36%
加载更多
公司概况
公司名称:
联康生物科技集团
所属市场:
SEHK
上市日期:
--
主营业务:
联康生物科技集团有限公司是一家主要从事医药产品制造及销售业务的香港投资控股公司。该公司通过四大分部运营。自制化学药品分部从事自制化学药品的制造及销售业务。其化学药品包括匹纳普等。自制生物药品分部从事自制生物药品的制造及销售。其生物药品包括金因肽及金因舒等。自制生物在研产品分部从事自制生物在研产品的规模化生产业务。其生物在研产品包括Uni-E4及Uni-PTH等。第三方药品分部从事第三方药品销售业务。
发行价格:
--
{"stockData":{"symbol":"00690","market":"HK","secType":"STK","nameCN":"联康生物科技集团","latestPrice":0.091,"timestamp":1779162831662,"preClose":0.089,"halted":0,"volume":640000,"delay":0,"changeRate":0.02247191011235957,"floatShares":5971000000,"shares":5971000000,"eps":0.0156,"marketStatus":"交易中","change":0.002,"latestTime":"05-19 11:58:10","open":0.089,"high":0.091,"low":0.089,"amount":57480,"amplitude":0.022472,"askPrice":0.091,"askSize":500000,"bidPrice":0.09,"bidSize":100000,"shortable":0,"etf":0,"ttmEps":0.015629,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1779163200000},"marketStatusCode":2,"adr":0,"listingDate":1005494400000,"exchange":"SEHK","adjPreClose":0.089,"dividendRate":0.03044,"openAndCloseTimeList":[[1779154200000,1779163200000],[1779166800000,1779177600000]],"volumeRatio":0.428491,"lotSize":20000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00690/news","defaultTab":"news","newsList":[{"id":"1196899537","title":"联康生物科技集团2026年4月股份变动月报:股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1196899537","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196899537?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:21","pubTimestamp":1777886474,"startTime":"0","endTime":"0","summary":"联康生物科技集团有限公司于2026年5月4日发布2026年4月证券变动月报表。公告显示,公司本月已发行股份数量为5,971,228,147股,库藏股份数量为0股,与上月末保持一致。另据公告披露,联康生物科技集团于报告期内共拥有9批次2016年股份期权计划,对应期权数量合计420,589,000股。截至4月底,相关股份期权数量及其行使情况均未发生变化,本月无新增股份发行或期权行权记录。据悉,本次公告由公司秘书何詠欣女士签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629839787","title":"联康生物科技集团(00690)建议终止现有购股权计划及采纳新购股权计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2629839787","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629839787?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:15","pubTimestamp":1776946548,"startTime":"0","endTime":"0","summary":"智通财经APP讯,联康生物科技集团(00690)发布公告,董事会已建议(i)终止现有购股权计划;及(ii)采纳新购股权计划,以供股东批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00690","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183742344","title":"联康生物科技集团拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1183742344","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183742344?lang=zh_cn&edition=full","pubTime":"2026-04-22 18:47","pubTimestamp":1776854850,"startTime":"0","endTime":"0","summary":"联康生物科技集团有限公司于香港联合交易所有限公司主板上市。根据最新公告,董事会建议寻求股东批准一项股份购回授权,最多回购相当于公司于相关决议案获股东大会通过当日已发行股份总数10%的股份。公告显示,截至决议案通过当日,公司已发行股份数约为5,971,228,147股,代表最多可回购约597,122,814股。根据公告提供的最近月份股价区间,联康生物科技集团股价曾在0.055港元至0.168港元之间波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"联康生物科技集团拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135819601","title":"联康生物科技集团2025年收入5.86亿元 净利同比增长12.7% 聚焦创新研发与国际化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1135819601","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135819601?lang=zh_cn&edition=full","pubTime":"2026-04-22 18:43","pubTimestamp":1776854621,"startTime":"0","endTime":"0","summary":"联康生物科技集团在截至2025年12月31日止年度实现收入5.86亿元,同比增长约6%。毛利为4.88亿元,毛利率约83%,与上年度水平基本持平。年度溢利达到0.93亿元,同比上升12.7%。除税前溢利约为1.02亿元,较上一年度的0.91亿元增长11.4%。此外,集团于报告期内的研发开支为0.40亿元,较上年度有所回落。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"联康生物科技集团2025年收入5.86亿元 净利同比增长12.7% 聚焦创新研发与国际化布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133486624","title":"联康生物科技集团3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1133486624","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133486624?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:42","pubTimestamp":1775637745,"startTime":"0","endTime":"0","summary":"联康生物科技集团有限公司(股票代码:00690)在2026年4月8日发布截至2026年3月31日的股份变动月报表。报告显示,公司本月内未有新增发行、库藏或注销股份活动,已发行普通股数依旧维持在5,971,228,147股,库存股份数为0股。\n根据公告,公司法定股本保持在500,000,000,000股,每股面值港币0.01元,总额为港币50亿。期权方面,多个先前授予的期权累计数量合计仍保持不变,报告期间未有期权行使或失效记录。\n公司强调,截至本月底已符合相关公众持股量要求,并确认遵守香港联交所《上市规则》及其他适用法律法规规定。公告由公司秘书何咏欣女士签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624703525","title":"联康生物科技集团(00690):股东股权框架变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2624703525","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624703525?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:08","pubTimestamp":1775124483,"startTime":"0","endTime":"0","summary":"联康生物科技集团(00690)发布公告,公司董事会获梁国龙先生(执行董事兼董事会主席)(梁先生)及其若干受控法团告知,由于梁先生及其家族成员组成的梁氏家族的家族安排,故有关股权发生变动(股权变动)。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_2.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_2.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622790858","title":"联康生物科技集团(00690)发布年度业绩 年内溢利9332.7万港元 同比增加12.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622790858","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622790858?lang=zh_cn&edition=full","pubTime":"2026-03-28 00:43","pubTimestamp":1774629796,"startTime":"0","endTime":"0","summary":"智通财经APP讯,联康生物科技集团(00690)发布截至2025年12月31日止年度业绩,该集团期内取得收益5.86亿港元,同比增加6%;年内溢利9332.7万港元,同比增加12.7%;每股基本盈利1.56港仙。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"联康生物科技集团(00690)发布年度业绩 年内溢利9332.7万港元 同比增加12.7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00690","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124133894","title":"联康生物科技集团将于2026年6月12日派发末期股息每股0.00313元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124133894","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124133894?lang=zh_cn&edition=full","pubTime":"2026-03-27 23:04","pubTimestamp":1774623869,"startTime":"0","endTime":"0","summary":"联康生物科技集团(00690)宣布,截至2025年12月31日止年度末期股息每股0.00313港元,股息尚待于2026年5月26日股东大会上批准。除净日为2026年5月28日,有意参与股息分派的股东须在2026年5月29日16时30分前递交股份过户登记文件。公司将于2026年6月1日至6月3日暂停办理股份过户登记,6月3日为记录日期,股息预计于2026年6月12日派发。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620563415","title":"联康生物科技集团(00690)股东将股票存入香港上海汇丰银行 存仓市值8715.96万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620563415","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620563415?lang=zh_cn&edition=full","pubTime":"2026-03-17 08:11","pubTimestamp":1773706266,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,3月16日,联康生物科技集团(00690)股东将股票存入香港上海汇丰银行,存仓市值8715.96万港元,占比13.64%。联康生物科技集团2025年中期业绩显示,收益3.10亿港元,同比增长13.4%;净利润7595.5万港元,同比增长12.7%;每股基本盈利1.27港仙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414647.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LU1481107354.HKD","LU2236285917.USD","LU0516423091.SGD","LU0348735423.USD","LU0052756011.USD","LU0417516738.SGD","LU2449936058.SGD","LU0164880469.USD","LU0634319403.HKD","BK1572","LU1267930227.SGD","LU0310800965.SGD","03143","HSBH","LU0516422952.EUR","BK4521","HSBC","HSBA.UK","LU0516423174.USD","LU0540923850.HKD","00005","LU0128525689.USD","BK1231","HSHD.SI","BK1610","BK1161","BK1601","BK4588","LU0516422366.SGD","LU0516422440.USD","LU0149721374.USD","BK4207","IE0008369823.USD","00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618611832","title":"联康生物科技集团盘中异动 早盘股价大跌7.27%报0.102港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618611832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618611832?lang=zh_cn&edition=full","pubTime":"2026-03-09 10:36","pubTimestamp":1773023810,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘10时36分,联康生物科技集团股票出现波动,股价快速下跌7.27%。截至发稿,该股报0.102港元/股,成交量158万股,换手率0.03%,振幅4.55%。资金方面,该股资金流入2140港元,流出11.06万港元。联康生物科技集团股票所在的药品行业中,整体跌幅为1.30%。联康生物科技集团公司简介:联康生物科技集团有限公司是一家主要从事医药产品制造及销售业务的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309103650a6b0c802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309103650a6b0c802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00690","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186017307","title":"联康生物科技集团(00690)2026年2月股份维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1186017307","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186017307?lang=zh_cn&edition=full","pubTime":"2026-03-03 10:21","pubTimestamp":1772504493,"startTime":"0","endTime":"0","summary":"联康生物科技集团有限公司于2026年3月3日发布2月股份变动月报表。报告期为2026年2月28日止,截至期末,公司法定股本维持在5000万港元,面值每股0.01港元,注册股本5000万港元无变化。公告显示,截至2026年2月28日止,公司普通股发行股份总数为5,971,228,147股,较上月底无新增发行、购回或注销记录;库藏股数为0股,与上月底持平。截至2月底,公司已发行股本规模保持不变,未发生其他股份变动。该公告由公司秘书何詠欣女士签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614616488","title":"联康生物科技集团盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614616488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614616488?lang=zh_cn&edition=full","pubTime":"2026-02-27 10:15","pubTimestamp":1772158529,"startTime":"0","endTime":"0","summary":"2026年02月27日早盘10时15分,联康生物科技集团股票出现波动,股价大幅上涨5.56%。截至发稿,该股报0.114港元/股,成交量10万股,换手率0.00%,振幅2.78%。联康生物科技集团股票所在的药品行业中,整体涨幅为0.29%。联康生物科技集团公司简介:联康生物科技集团有限公司是一家主要从事医药产品制造及销售业务的香港投资控股公司。其生物药品包括金因肽及金因舒等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227101529a4cdb960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227101529a4cdb960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00690","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613080765","title":"联康生物科技集团02月23日主力净流出59.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613080765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613080765?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:15","pubTimestamp":1771834507,"startTime":"0","endTime":"0","summary":"02月23日, 联康生物科技集团股价跌1.75%,报收0.11元,成交金额224.6万元,换手率0.34%,振幅5.26%,量比18.46。联康生物科技集团今日主力资金净流出59.6万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.65%,主力资金累计净流出59.6万元;近20日主力资金累计净流出104.9万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161516a71556de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161516a71556de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610668018","title":"联康生物科技集团02月09日主力净流入16.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610668018","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610668018?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624916,"startTime":"0","endTime":"0","summary":"02月09日, 联康生物科技集团股价涨1.80%,报收0.11元,成交金额103.0万元,换手率0.15%,振幅4.50%,量比1.43。联康生物科技集团今日主力资金净流入16.9万元,上一交易日主力净流出0万元。该股近5个交易日上涨1.80%,主力资金累计净流出6.1万元;近20日主力资金累计净流出45.3万元,其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209161603a48e4100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209161603a48e4100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00690","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608760876","title":"联康生物科技集团02月03日主力净流出23.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608760876","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608760876?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106525,"startTime":"0","endTime":"0","summary":"02月03日, 联康生物科技集团股价跌0.90%,报收0.11元,成交金额160.1万元,换手率0.25%,振幅9.01%,量比1.58。联康生物科技集团今日主力资金净流出23.1万元,上一交易日主力净流出0万元。该股近5个交易日上涨0.93%,主力资金累计净流出21.4万元;近20日主力资金累计净流出33.0万元,其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161651a6cda24a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161651a6cda24a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607006564","title":"联康生物科技集团盘中异动 快速拉升5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607006564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607006564?lang=zh_cn&edition=full","pubTime":"2026-01-29 11:18","pubTimestamp":1769656730,"startTime":"0","endTime":"0","summary":"2026年01月29日早盘11时18分,联康生物科技集团股票出现波动,股价急速拉升5.61%。联康生物科技集团股票所在的药品行业中,整体涨幅为0.22%。其相关个股中,英硅智能、联康生物科技集团、兆科眼科-B涨幅较大,振幅较大的相关个股有英硅智能、泰德医药、君圣泰医药-B,振幅分别为11.22%、7.86%、7.61%。联康生物科技集团公司简介:联康生物科技集团有限公司是一家主要从事医药产品制造及销售业务的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129111850953ed820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129111850953ed820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606271161","title":"联康生物科技集团盘中异动 股价大跌5.31%报0.107港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606271161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606271161?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:15","pubTimestamp":1769483715,"startTime":"0","endTime":"0","summary":"2026年01月27日早盘11时15分,联康生物科技集团股票出现波动,股价大幅下跌5.31%。截至发稿,该股报0.107港元/股,成交量578万股,换手率0.10%,振幅5.31%。资金方面,该股资金流入6.202万港元,流出47万港元。联康生物科技集团股票所在的药品行业中,整体跌幅为0.70%。联康生物科技集团公司简介:联康生物科技集团有限公司是一家主要从事医药产品制造及销售业务的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127111515a45a18e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127111515a45a18e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00690","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606227829","title":"智通港股股东权益披露|1月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2606227829","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606227829?lang=zh_cn&edition=full","pubTime":"2026-01-27 08:05","pubTimestamp":1769472302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,联康生物科技集团(00690)于2026年1月27日进行了最新股东权益披露。股票名称机构名称性质变动前持股变动后持股持股比联康生物科技集团(00690)闻亚磊好仓1.78 亿股1.76 亿股2.95%(最新)2.99%(前次)备注:持股数变动有可能因供股、合股、拆股等情况引起,请注意对照实际情况进行辨别。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605446184","title":"联康生物科技集团盘中异动 临近午盘股价大跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605446184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605446184?lang=zh_cn&edition=full","pubTime":"2026-01-22 11:36","pubTimestamp":1769052962,"startTime":"0","endTime":"0","summary":"2026年01月22日临近午盘11时36分,联康生物科技集团股票出现异动,股价快速下跌5.83%。截至发稿,该股报0.113港元/股,成交量252万股,换手率0.04%,振幅5.83%。资金方面,该股资金流入7140港元,流出25.848万港元。联康生物科技集团股票所在的药品行业中,整体跌幅为0.18%。联康生物科技集团公司简介:联康生物科技集团有限公司是一家主要从事医药产品制造及销售业务的香港投资控股公司。其生物药品包括金因肽及金因舒等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122113602953dd4a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122113602953dd4a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00690"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601800743","title":"联康生物科技集团盘中异动 早盘快速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601800743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601800743?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:38","pubTimestamp":1767749935,"startTime":"0","endTime":"0","summary":"2026年01月07日早盘09时38分,联康生物科技集团股票出现异动,股价急速拉升5.36%。联康生物科技集团股票所在的药品行业中,整体涨幅为0.07%。其相关个股中,联康生物科技集团、石药集团、翰森制药涨幅较大,振幅较大的相关个股有翰森制药、石药集团、联康生物科技集团,振幅分别为4.98%、4.06%、3.57%。联康生物科技集团公司简介:联康生物科技集团有限公司是一家主要从事医药产品制造及销售业务的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107093855a6fc60d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107093855a6fc60d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00690","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.uni-bioscience.com","stockEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":-0.11},{"period":"3month","weight":-0.2261},{"period":"6month","weight":-0.2393},{"period":"1year","weight":0.2027},{"period":"ytd","weight":-0.2261}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0185},{"period":"3month","weight":-0.0386},{"period":"6month","weight":-0.006},{"period":"1year","weight":0.0998},{"period":"ytd","weight":0.0017}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"联康生物科技集团有限公司是一家主要从事医药产品制造及销售业务的香港投资控股公司。该公司通过四大分部运营。自制化学药品分部从事自制化学药品的制造及销售业务。其化学药品包括匹纳普等。自制生物药品分部从事自制生物药品的制造及销售。其生物药品包括金因肽及金因舒等。自制生物在研产品分部从事自制生物在研产品的规模化生产业务。其生物在研产品包括Uni-E4及Uni-PTH等。第三方药品分部从事第三方药品销售业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.409091,"avgChangeRate":0.00252},{"month":2,"riseRate":0.521739,"avgChangeRate":0.058511},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.009335},{"month":4,"riseRate":0.47619,"avgChangeRate":0.111842},{"month":5,"riseRate":0.47619,"avgChangeRate":0.04424},{"month":6,"riseRate":0.47619,"avgChangeRate":0.059293},{"month":7,"riseRate":0.52381,"avgChangeRate":0.016613},{"month":8,"riseRate":0.47619,"avgChangeRate":-0.020815},{"month":9,"riseRate":0.380952,"avgChangeRate":0.496978},{"month":10,"riseRate":0.238095,"avgChangeRate":-0.045167},{"month":11,"riseRate":0.47619,"avgChangeRate":-0.023386},{"month":12,"riseRate":0.318182,"avgChangeRate":-0.003177}],"exchange":"SEHK","name":"联康生物科技集团","nameEN":"UNI-BIO GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联康生物科技集团(00690)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联康生物科技集团(00690)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联康生物科技集团,00690,联康生物科技集团股票,联康生物科技集团股票老虎,联康生物科技集团股票老虎国际,联康生物科技集团行情,联康生物科技集团股票行情,联康生物科技集团股价,联康生物科技集团股市,联康生物科技集团股票价格,联康生物科技集团股票交易,联康生物科技集团股票购买,联康生物科技集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联康生物科技集团(00690)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联康生物科技集团(00690)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}